ATLANTA, Georgia, Feb. 24 -- Cancer, a peer-reviewed journal from the American Cancer Society that says it features cancer research, risk reduction, treatment and patient care, published research articles on the following topics, in its March 15, 2024, edition (Vol. 130, Issue 6):

Cancer Scope:

* FDA approves capivasertib with fulvestrant for breast cancer

* FDA authorizes blood test for risk assessment of hereditary cancers

COMMENTARY:
. . .

Click here for more information about our products